University of Oxford launches first human aerosol TB vaccine trial

University of Oxford launches first human aerosol TB vaccine trial

The University of Oxford, in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI), has commenced a new clinical trial called TB-45, which will test tuberculosis (TB) vaccine safety, the first-in-human aerosol mycobacterial challenge infection model TB is an infection that predominantly affects the lungs and causes symptoms such as a cough, a loss of appetite, weight loss, and exhaustion. To strengthen defences against T…